Aimei Health Technology Co., Ltd

AFJK

NASDAQFinancial ServicesShell Companies

Open in GoAI

Previous close

$12.56

+$0.23 · +1.87%

Aug 21, 4:00 PM ET

Pre-market

$12.40

−$0.16 · -1.27%

Aug 24, 7:52 AM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

29/100

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

Expensive

Momentum

Weakening

Sentiment

Mixed

Risk resilience

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Aimei Health Technology Co., Ltd. currently lacks substantial business operations. Its core purpose is to pursue a strategic business combination, which may take the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar transaction with one or more companies. The firm intends to acquire businesses operating in the biopharmaceutical, medical technology/device, diagnostic, and other service-related industries. Aimei Health Technology Co., Ltd. was established in 2023 and is based in New York, New York.

Industry: Shell Companies
Sector: Financial Services
Headquarters: US
CEO: Junheng Xie
Listed since: Jan 22, 2024
Employees: 2

Market position

Day range

Current $12.56

$12.30$13.00

52-week range

Current $12.56

$6.75$130.37

Open: $12.50
Previous close: $12.33
Volume: 23.96K; 1.46× average
Average volume: 16.44K; Average daily volume
Market cap: 39.77M USD
Beta: 0.55; Market reference 1
50-day average: $18.5045; -32.12% below average
200-day average: $33.0394; -61.98% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 261.09M USD
P/E (TTM): 184.16×
P/B (TTM): 1.63×
P/S (TTM): 0×
EV / EBITDA: -312.4×
Earnings yield: 0.41%
Free cash flow yield: -0.22%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 0.00%
Operating margin: 0.00%
Net margin: 0.00%
Return on equity: 13.18%
Return on assets: 8.76%
Return on invested capital: -7.77%

Financial health

Debt / equity: 0.27×
Current ratio: 0×

Financial statements

Income trends

Operating income

−835.76K USD+21.52%

Net income

1.06M USD-58.47%

Metric (USD)	FY2025	FY2024	FY2023
Selling, general, and administrative	835.76K USD	—	28.46K USD
Operating expenses	835.76K USD	1.07M USD	28.46K USD
Interest income	1.9M USD	3.62M USD	199.85K USD
Operating income	−835.76K USD	−1.07M USD	−28.46K USD
Net income	1.06M USD	2.55M USD	171.39K USD